Maxは、科学的なバックグラウンドとヘルスケア製品開発における実務経験の両方を兼ね備えており、開発中および上市済み製品におけるエビデンスに基づくバリュー＆アクセス戦略の構築において重要な役割を果たします。Leading a team of analysts and focusing on projects involving late stage, launch, and due diligence efforts, Max’ experience cuts across all major therapeutic areas and care settings with special emphasis on CV / metabolic, oncology, gene therapies, ophthalmology, GI, and dermatology. Max and team have designed successful pricing and contracting strategies for products at launch and throughout the life cycle. He also leads projects focusing on managed markets communications strategies.